U.T. Vibrance
On sale on the US market (according to the DSLD)
Vibrant Health, food supplement from the US market
U.T. Vibrance (Vibrant Health), a food supplement au code-barres 074306800305, is described by its US market label. The French and European rules we can apply to this label flag no particular point. The formula sold in Europe under the same name may differ.
Official label. Dietary Supplement Label Database (DSLD), US National Institutes of Health: current and off-market labels, retrieved 27 October 2026.
Source: NIH Office of Dietary Supplements, Dietary Supplement Label Database (CC0); US market labels.
If this product were sold in France
No point flagged by the rules we apply.
A daily dose is calculated only if the label gives the maximum number of servings and a unit of mass (or international units for vitamin D). Quantities come from the label, not an analysis. In the United States, the label presents this product as a ‘dietary supplement’; in France, a product of this type may belong to another category (a sports powder, for example), and maximum food supplement doses do not apply to it.
Label composition
- Brand
- Vibrant Health
- Barcode
- 074306800305
- Form
- Powder
- One serving
- 6.46 g
- Servings
- up to 4 servings per day
| Ingredient (as written, in English) | Category | Per serving |
|---|---|---|
| D-Mannose | Carbohydrate | 5,000 mg |
| Uva Ursi extract (Arctostaphylos uva-ursi) | Plant | 125 mg |
| Blueberry fruit powder | Plant | 125 mg |
| Cranberry whole fruit powder | Plant | 125 mg |
| Dandelion root 4:1 extract | Plant | 125 mg |
| Goldenrod aerial parts powder | Plant | 125 mg |
| Goldenseal root powder (Hydrastis canadensis) | Plant | 50 mg |
| Parsley aerial parts juice powder (Petroselinum crispum) | Plant | 50 mg |
Displayed label: Official label. Labels on the market are prioritised, followed by the most recent for the same status.
Other versions of this label
The differences below describe each other version relative to the label shown on this page. They concern active ingredient rows and quantities per serving as written. Missing quantities are not estimated and different units are not converted. Dates refer to entry into DSLD, not necessarily to a formula change.
Official label: U.T. Vibrance
Entered into DSLD on 24 June 2020. On sale on the US market (according to the DSLD).Same active composition.
Official label: U.T. Vibrance
Entered into DSLD on 25 January 2020. Withdrawn from the US market on 25 July 2019 (according to the DSLD).Same active composition.
Official label: U.T. Vibrance
Entered into DSLD on 20 November 2017. Withdrawn from the US market on 13 February 2019 (according to the DSLD).- Same quantity, different name: Uva Ursi in this version; Uva Ursi extract on the displayed label (125 mg)
- Different unit, without conversion : D-Mannose: 5 Gram(s) in this version; 5,000 mg on the displayed label
Official label: U.T. Vibrance
Entered into DSLD on 24 March 2017. Withdrawn from the US market on 31 August 2017 (according to the DSLD).- Active ingredient added : Dandelion root 4:1 ext. (125 mg)
- Active ingredient added : Uva Ursi (125 mg)
- Active ingredient removed : Dandelion root 4:1 extract (125 mg)
- Active ingredient removed : Uva Ursi extract (125 mg)
- Different unit, without conversion : D-Mannose: 5 Gram(s) in this version; 5,000 mg on the displayed label
Official label: U.T. Vibrance
Entered into DSLD on 23 December 2015. Withdrawn from the US market on 30 December 2015 (according to the DSLD).- Active ingredient added : Dandelion root 4:1 ext. (125 mg)
- Active ingredient added : Uva Ursi (125 mg)
- Active ingredient removed : Dandelion root 4:1 extract (125 mg)
- Active ingredient removed : Uva Ursi extract (125 mg)
- Different unit, without conversion : D-Mannose: 5 Gram(s) in this version; 5,000 mg on the displayed label
Official label: U.T. Vibrance
Entered into DSLD on 29 December 2014. Withdrawn from the US market on 19 November 2015 (according to the DSLD).- Active ingredient added : Blueberry (125 mg)
- Active ingredient added : Cranberry (125 mg)
- Active ingredient added : Dandelion (125 mg)
- Active ingredient added : European Goldenrod (125 mg)
- Active ingredient added : Goldenseal (50 mg)
- Active ingredient added : Parsley (aerial parts) juice (50 mg)
- Active ingredient added : Uva-Ursi leaf extract (125 mg)
- Active ingredient removed : Blueberry fruit powder (125 mg)
- Active ingredient removed : Cranberry whole fruit powder (125 mg)
- Active ingredient removed : Dandelion root 4:1 extract (125 mg)
- Active ingredient removed : Goldenrod aerial parts powder (125 mg)
- Active ingredient removed : Goldenseal root powder (50 mg)
- Active ingredient removed : Parsley aerial parts juice powder (50 mg)
- Active ingredient removed : Uva Ursi extract (125 mg)
- Different unit, without conversion : D-Mannose: 5 Gram(s) in this version; 5,000 mg on the displayed label
This information reproduces the US label recorded by the US National Institutes of Health (NIH). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.
Official warnings (Health Canada)
Health Canada publishes warnings on these ingredients:
- Uva Ursi extract
Read the warning, when it applies and the studies cited
Bearberry - Arctostaphylos Uva-Ursi
Route of administration: Oral
Cautions and warnings
Condition of application: All products.
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
Applies to products providing 60 milligrams or more of dried leaves and/or products providing 20 milligrams or more of Arbutin, per day.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have a liver disorder, fever, painful urination (dysuria), spasms, or blood in urine (EMA 2018; Duke 2002; Newall 1996).
Sources cited by Health Canada (2)
- EMA 2018: EMA/HMPC/750269/2016. European Union herbal monograph on Arctostaphylos uva-ursi (L.) Spreng., folium. London (GB): European Medicines Agency: Committee on Herbal Medicinal Products (HMPC); 2018 January 30. [Accessed 2024 June 11]. Available from: https://www.ema.europa.eu/en/documents/herbal-monograph/final-european-union-herbal-monograph-arctostaphylos-uva-ursi-l-spreng-folium-revision-2_en.pdf
- Newall CA, Anderson LA, Phillipson JD. Herbal Medicines: A guide for health-care professionals. London (GB): The Pharmaceutical Press; 1996.
1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).
Contraindications
Do not use if you are pregnant or breastfeeding (EMA 2018; Brinker 2010; ESCOP 2003; WHO 2002; Blumenthal 2000; Mills and Bone 2000; Bradley 1992).
Sources cited by Health Canada (8)
- Blumenthal M, Goldberg A, Brinckmann J, editors. Herbal Medicine: Expanded Commission E Monographs. Newton (MA): Integrative Medicine Communications; 2000.
- Bradley PR, editor. British Herbal Compendium Volume 1: A Handbook of Scientific Information on Widely Used Plant Drugs - Companion Volume 1 of the British Herbal Pharmacopoeia. Bournemouth (GB): British Herbal Medicine Association; 1992.
- Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
- EMA 2018: EMA/HMPC/750269/2016. European Union herbal monograph on Arctostaphylos uva-ursi (L.) Spreng., folium. London (GB): European Medicines Agency: Committee on Herbal Medicinal Products (HMPC); 2018 January 30. [Accessed 2024 June 11]. Available from: https://www.ema.europa.eu/en/documents/herbal-monograph/final-european-union-herbal-monograph-arctostaphylos-uva-ursi-l-spreng-folium-revision-2_en.pdf
- ESCOP 2003: European Scientific Cooperative of Phytotherapy. ESCOP Monographs: The Scientific Foundation for Herbal Medicinal Products, 2nd edition completely revised and expanded. Exeter (GB): European Scientific Cooperative on Phytotheraphy; 2003.
- Mills S, Bone K. Principles and Practice of Phytotherapy, Modern Herbal Medicine. Edinburg (GB): Churchill LYes Soivingston; 2000.
- WHO 2002: World Health Organization. WHO Monographs on Selected Medicinal Plants, Volume 3. Geneva (CH): World Health Organization; 2002.
- OMS 2002: Organisation mondiale de la santé (OMS). Monographs on Selected Medicinal Plants : Volume 3. Genève (CH): Organisation mondiale de la santé; 2002.
- Goldenseal root powder
Read the warning, when it applies and the studies cited
GOLDENSEAL - HYDRASTIS CANADENSIS - Buccal
Cautions and warnings
Stop use and ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms worsen or last (for) more than 7 days.
Ask a health care practitioner/health care provider/health care professional/ doctor/physician before use if you have a kidney or blood pressure disorder (Brinker 2010; Hoffmann 2003).
Sources cited by Health Canada (2)
- Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
- Hoffmann D. Medical Herbalism. Rochester (VT): Healing Arts Press; 2003.
Contraindications
Do not use if you are pregnant or breastfeeding (Gardner and McGuffin 2013; Brinker 2010; Barnes and al. 2007; Mills and Bone 2005; Boon and Smith 2004; Hoffmann 2003; Bradley 1992).
Sources cited by Health Canada (7)
- Barnes J, Anderson LA, Philipson JD. Herbal Medicines, 3rd edition. London (GB): The Pharmaceutical Press; 2007.
- Boon H, Smith MJ. The Complete Natural Medicine Guide to the 50 Most Common Medicinal Herbs, 2nd edition. Toronto (ON): Robert Rose Inc; 2004.
- Bradley PR, editor. British Herbal Compendium, Volume 1. Bournemouth (GB): British Herbal Medicine Association; 1992.
- Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
- Gardner Z, McGuffin M, editors. American Herbal Products Association's Botanical Safety Handbook. 2nd edition. Boca Raton (FL): Taylor and Francis Group; 2013.
- Hoffmann D. Medical Herbalism. Rochester (VT): Healing Arts Press; 2003.
- Mills S, Bone K. The Essential Guide to Herbal Safety. St. Louis (MO): Elsevier Churchill Livingstone; 2005.
Health Canada monograph dated 28 March 2025
GOLDENSEAL - HYDRASTIS CANADENSIS - Oral
Cautions and warnings
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
Ask a health care practitioner/health care provider/health care professional before use if you have a kidney or blood pressure disorder (Brinker 2010; Hoffmann 2003).
Sources cited by Health Canada (2)
- Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
- Hoffmann D. 2003. Medical Herbalism. Rochester (VT): Healing Arts Press.
Contraindications
Do not use if you are pregnant or breastfeeding (Gardner and McGuffin 2013; Brinker 2010; Barnes and al. 2007; Mills and Bone 2005; Boon and Smith 2004; Hoffmann 2003; Bradley 1992).
Sources cited by Health Canada (7)
- Barnes J, Anderson LA, Philipson JD. 2007. Herbal Medicines, 3rd edition. London (GB): The Pharmaceutical Press.
- Boon H, Smith MJ. 2004. The Complete Natural Medicine Guide to the 50 Most Common Medicinal Herbs, 2nd edition. Toronto (ON): Robert Rose Inc.
- Bradley PR, editor. 1992. British Herbal Compendium, Volume 1. Bournemouth (GB): British Herbal Medicine Association.
- Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
- Gardner Z, McGuffin M, editors. American Herbal Products Association's Botanical Safety Handbook. Second Edition. Boca Raton (FL): Taylor and Francis Group; 2013.
- Hoffmann D. 2003. Medical Herbalism. Rochester (VT): Healing Arts Press.
- Mills S, Bone K. 2005. The Essential Guide to Herbal Safety. St. Louis (MO): Elsevier Churchill Livingstone.
They concern the ingredient, not this product or its dose. They do not replace medical advice.
List declared on (register: Dietary Supplement Label Database (DSLD), US National Institutes of Health: current and off-market labels).
Brand : Vibrant Health
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.
Cite this page: CompoAtlas, “U.T. Vibrance (Vibrant Health): composition and French regulation”, https://compoatlas.com/en/supplements/us-labels/74306800305-u-t-vibrance-vibrant-health, updated 24 September 2021.